EP4125896
TREATMENT OF TYPE 2 DIABETES WITH 2-[(4-{6-[(4-CYANO-2-FLUOROBENZYL)OXY]PYRIDIN-2-YL} PIPERIDIN-1-YL)METHYL]-1-[(2S)-OXETAN-2-YLMETHYL]-1H-BENZIMIDAZOLE-6-CARBOXYLIC ACID OR A PHARMACEUTICALLY SALT TH
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
24.3.2021EP published:
7.5.2025EP application number:
21714685.1
EPO information:
European Patent Register
Max expiry date:
23.3.2041
Title in English:
TREATMENT OF TYPE 2 DIABETES WITH 2-[(4-{6-[(4-CYANO-2-FLUOROBENZYL)OXY]PYRIDIN-2-YL} PIPERIDIN-1-YL)METHYL]-1-[(2S)-OXETAN-2-YLMETHYL]-1H-BENZIMIDAZOLE-6-CARBOXYLIC ACID OR A PHARMACEUTICALLY SALT THLanguage of the patent:
English
Timeline
Today
24.3.2021EP application
7.5.2025EP Publication
Owner
Name:
Pfizer Inc.Address:
66 Hudson Boulevard East, New York, NY 10001-2192, US
Inventor
Name:
LEE, Kai TeckAddress:
Sandwich Kent CT13 9NJ, GB
Name:
MANTHENA, SwetaAddress:
Groton, Connecticut 06340, US
Name:
SAXENA, Aditi RaoAddress:
Cambridge, Massachusetts 02139, US
Priority
Number:
202063000787 PDate:
27.3.2020Country:
US
Number:
202063126113 PDate:
16.12.2020Country:
US
Number:
202163135870 PDate:
11.1.2021Country:
US
Classification
Categories:
A61K 31/4545, A61P 3/04, A61P 3/10, A61K 9/20